Correction: miR-221 Exerts Antiviral and Anti-Inflammatory Effects against HSV-1 Through Direct Repression of CAMK2A and Immune Pathway Activation. [PDF]
Xu J +5 more
europepmc +1 more source
A CDK-4EBP1 signaling axis drives HSV-1 replication and underscores a druggable pathway for potent antiviral intervention. [PDF]
Madavaraju K +5 more
europepmc +1 more source
Gellan Gum/Alginate Films Containing Biogenic <i>uva ursi</i> Silver Nanoparticles: Analytical Characterization and Antiviral Activity Against HSV-1. [PDF]
Della Marca R +9 more
europepmc +1 more source
Development of RNase P ribozyme-based therapy against oral herpesvirus infections by HSV-1 and KSHV. [PDF]
Sorrell T, Liu F.
europepmc +1 more source
STING activates ZBP1-mediated PANoptosis to defend against HSV-1 retinal infection. [PDF]
Liu W +13 more
europepmc +1 more source
Restriction of HSV-1 replication by Pistacia vera L. extracts reveals a promising strategy for regulating virus-mediated chemokine response in monocytic cells. [PDF]
Pennisi R +5 more
europepmc +1 more source
Collagen Analogs Promote Tissue Regeneration in HSV-1-Infected Corneas in Animal Models. [PDF]
Buznyk O +9 more
europepmc +1 more source
Enhanced AAV production via rational design of a novel pHelper vector integrated with HSV-1 helper genes. [PDF]
Ren H +5 more
europepmc +1 more source
A nanobody specific to prefusion glycoprotein B neutralizes HSV-1 and HSV-2. [PDF]
Vollmer B +9 more
europepmc +1 more source

